Los Angeles, CA – A novel drug candidate for glioblastoma, KTM-101, developed by researchers at the University of California, Los…
Read More
AbbVie Secures FDA Approval for Ultra-Rare Blood Cancer Therapy, While AstraZeneca Faces Delay for Breast Cancer Drug
The U.S. Food and Drug Administration (FDA) has recently issued a significant approval for AbbVie’s antibody-drug conjugate (ADC) targeting blastic…
Read More
Innovative Bone Marrow-on-a-Chip Platform Developed by Penn and CHOP Researchers to Revolutionize Drug Testing and Aerospace Medicine
Deep within the skeletal framework of the human body lies a complex, high-performance factory: the bone marrow. This sponge-like tissue…
Read More
Recent Biotech Bi-Weekly Highlights Breakthroughs in Alzheimer’s Modeling and Lab Automation, Fueling Drug Discovery Hopes
In a significant development for neurodegenerative disease research, 28bio, a biotechnology firm based in Los Angeles, USA, has announced the…
Read More
Popular Anti-Aging Drug Combination Linked to Significant Brain Damage and Myelin Loss in New Study
A drug combination that has become a cornerstone of modern longevity research may carry unforeseen and devastating consequences for neurological…
Read More
A Novel Drug Screening Platform Revolutionizes Approach to Neurological and Psychiatric Disorders by Targeting Protein Expression Imbalances
Researchers have developed an innovative drug screening platform designed to identify compounds that precisely target the primary cause of numerous…
Read More
Insilico Medicine and Eli Lilly Forge Potentially $2.75 Billion AI-Driven Drug Discovery Alliance, Signaling a New Era of Pharmaceutical Innovation
On March 29, Insilico Medicine, a pioneering company in artificial intelligence-driven drug discovery and development, announced a landmark collaboration with…
Read More
OpenBench and Concept Life Sciences Forge Strategic Alliance to Revolutionize Early-Stage Drug Discovery with Fee-for-Success Model
A groundbreaking strategic partnership has been announced between OpenBench, a pioneer in AI-driven drug discovery, and Concept Life Sciences, a…
Read More
Innovative Bioengineered Bone Marrow-on-a-Chip Platform Replicates Human Hematopoietic Systems to Revolutionize Drug Development and Space Exploration
In a landmark advancement for regenerative medicine and bioengineering, a multidisciplinary team of researchers from the University of Pennsylvania School…
Read More
Billion Cell Atlas Unveiled: A New Horizon for AI-Driven Drug Discovery and Disease Understanding
In a landmark initiative poised to revolutionize pharmaceutical research, scientists have announced the launch of the Billion Cell Atlas, an…
Read MoreYOU MAY HAVE MISSED
